![](https://investorshub.advfn.com/uicon/373583.png?cb=1492766821)
Thursday, October 01, 2015 8:56:52 AM
1) 4Million financing potential, not just the 1.2 MLL
2)The studies are investigating the optimization of the PRP treatment, which are expected to even further improve PRP's anti-tumor effects compared to the previous pilot studies. NOTICE the PRP has already show to be effective, and the studies now underway are tweeking this application to increase the already effective substance.
3) Two studies are well underway in the USA; Animal studies at Adaptive Biotechnologies in Seattle Washington; Animal studies well underway at VivoPharm in Hershey PA....
4) Mngt is targeting both the USA and Europe and preparation is underway for ODD.
WOW! These next few months look to be the ones we've been waiting for. October has all the right stuff to be a HUGE month.
Very relieved and excited about this update!!
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM